ReviewCancer immunology, immunotherapy : CII2015

CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?

Luana Calabrò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.